Status:
UNKNOWN
Surgical Strategies in Moderate Ischemic Mitral Insufficiency in Patients Undergoing Coronary Artery Bypass Graft
Lead Sponsor:
Assiut University
Conditions:
Moderate Ischemic Mitral Regurgitation
Eligibility:
All Genders
Brief Summary
Ischemic mitral regurgitation (IMR) is a common complication of myocardial infarction, with a reported prevalence of 13-59%. Approximately one-third of these patients have at least moderate MR .
Detailed Description
Ischemic mitral regurgitation (IMR) is a common complication of myocardial infarction, with a reported prevalence of 13-59%. Approximately one-third of these patients have at least moderate MR . The ...
Eligibility Criteria
Inclusion
- All patient with multi-vessel coronary artery disease with moderate degree of ischemic mitral regurgitation .
- Patient undergone surgery using cardiopulmonary bypass.
- Patient done on elective basis
Exclusion
- CABG done by off-pump technique.
- patients not candidates for complete revascularization.
- patients with other valvular affection other than mitral valve.
- Patients done on emergency basis.
- patient known to have Rheumatic valvular heart disease.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04279678
Start Date
March 1 2020
End Date
December 1 2023
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university Hospital
Asyut, Egypt, 71515